
TTP’s Advanced Therapies team partners with therapeutic developers to overcome the manufacturing bottlenecks that stand between breakthrough science and commercial success. We help clients identify the constraints limiting scale, then develop tailored technologies that improve cost, quality and throughput where existing solutions fall short. The result is a lower-risk route to commercial-scale manufacturing that enables faster progression through clinical and commercial milestones while retaining ownership and control of the manufacturing process.